Page 92 - Read Online

McNamee. J Transl Genet Genom 2018;2:20. I https://doi.org/10.20517/jtgg.2018.24 Page 7 of 7

10. Genomics England. 100,000 genome project. Available from: https://www.genomicsengland.co.uk. [Last accessed on 1 Nov 2018]
11. UK Pharmacogenetics and Stratified Medicine Network. NHS England’s policy and infrastructure plans - Ellen Graham. Available from:
http://www.uk-pgx-stratmed.co.uk/index.php/nhs-england-s-policy-and-infrastructure-plans-ellen-graham.html. [Last accessed on 1 Nov
2018]
12. U-PGx. U-PGx PREPARE study. Available from: http://upgx.eu/study. [Last accessed on 1 Nov 2018]
13. Personalized Medicine Coalition. Personalized medicine at FDA: 2017 progress report. Available from: http://www.personalizedmedicineco-
alition.org/Userfiles/PMC-Corporate/file/PM_at_FDA_2017_Progress_Report.pdf. [Last accessed on 1 Nov 2018]
14. Spear BB, Heath-Chiozzi M, Huff J. Clinical application of pharmacogenetics. Trends Mol Med 2001;7:201-4.
15. Chaponda M, Pirmohamed M. Hypersensitivity reactions to HIV therapy. Br J Clin Pharmacol 2011;71:659-71.
15. UK Pharmacogenetics and Stratified Medicine Network. Pharmacogenomics of serious adverse drug reactions - Munir Pirmohamed. Avail-
able from: http://www.uk-pgx-stratmed.co.uk/index.php/pharmacogenomics-of-serious-adverse-drug-reactions-munir-pirmohamed.html.
[Last accessed on 1 Nov 2018]
16. Osanlou O, Pirmohamed M, Daly AK. Pharmacogenetics of adverse drug reactions. Adv Pharmacol 2018;83:155-90.
17. Doostparast Torshizi A, Wang K. Next-generation sequencing in drug development: target identification and genetically stratified clinical
trials. Drug Discov Today 2018;23:1776-83.
18. Paul SM, Mytelka DS, Dunwiddie CT, Persinger CC, Munos BH, et al. How to improve R&D productivity: the pharmaceutical industry’s
grand challenge. Nat Rev Drug Discov 2010;9:203-14.
19. Simon R. Critical review of umbrella, basket, and platform designs for oncology clinical trials. Clin Pharmacol Ther 2017;102:934-41.
20. Roberts J, Middleton A. Genetics in the 21st Century: implications for patients, consumers and citizens. Version 2. F1000Res 2017;6:2020.
21. UK Pharmacogenetics and Stratified Medicine Network. Available from: http://www.uk-pgx-stratmed.co.uk. [Last accessed on 1 Nov 2018]